000728:SZSEGuoyuan Securities Company Limited Analysis
Data as of 2026-03-07 - not real-time
CN¥7.97
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Guoyuan Securities is trading at ¥7.97, which sits above its DCF‑derived fair value of ¥7.17, indicating a near‑term pricing premium. The stock has slipped below its 20‑day (¥8.20), 50‑day (¥8.36) and 200‑day (¥8.43) simple moving averages, a classic bearish signal. Momentum metrics reinforce the downside bias: the MACD histogram is negative (‑0.037) and the RSI rests at 36, suggesting limited upside momentum. Volume trends are weakening, with a “decreasing” volume pattern despite an average 10‑day volume of ~28 M shares, hinting at waning buying interest. On the valuation front, the PE of 13 is below the industry average of 17.5, and the P/B of 0.93 is under 1, reflecting a value‑oriented pricing profile.
Fundamentally, revenue growth is modest at 2.3% and ROE is only 7.4%, while the balance sheet carries a high debt‑to‑equity ratio of 252, flagging financial leverage risk. Nonetheless, the company generates strong cash flow (operating cash flow ¥4.45 bn) and maintains a dividend yield of 2.26% with a modest payout ratio of 16%, supporting dividend sustainability. The beta of ~0.2 (computed) and a 30‑day volatility of 18% suggest limited systematic risk but noticeable price swings. The overall risk landscape is tempered by a solid market cap of ¥34.8 bn and a “Greed” sentiment index (68.8), yet regulatory and geographic exposures in China remain material. Given the bearish technical backdrop, elevated leverage, and a price that exceeds intrinsic value, the near‑term outlook leans toward downside, while the dividend and value metrics provide a modest floor for longer horizons.
Fundamentally, revenue growth is modest at 2.3% and ROE is only 7.4%, while the balance sheet carries a high debt‑to‑equity ratio of 252, flagging financial leverage risk. Nonetheless, the company generates strong cash flow (operating cash flow ¥4.45 bn) and maintains a dividend yield of 2.26% with a modest payout ratio of 16%, supporting dividend sustainability. The beta of ~0.2 (computed) and a 30‑day volatility of 18% suggest limited systematic risk but noticeable price swings. The overall risk landscape is tempered by a solid market cap of ¥34.8 bn and a “Greed” sentiment index (68.8), yet regulatory and geographic exposures in China remain material. Given the bearish technical backdrop, elevated leverage, and a price that exceeds intrinsic value, the near‑term outlook leans toward downside, while the dividend and value metrics provide a modest floor for longer horizons.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- price below all major SMAs
- bearish MACD and low RSI
- proximity to support level and decreasing volume
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- dividend yield 2.26% with low payout
- PE below industry average
- high debt-to-equity constrains upside
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- sustainable dividend despite leverage
- value-oriented valuation metrics
- regulatory environment may limit growth
Key Metrics & Analysis
Financial Health
Revenue Growth2.30%
Profit Margin30.42%
P/E Ratio13.1
ROE7.36%
ROA1.58%
Debt/Equity251.72
P/B Ratio0.9
Op. Cash FlowCN¥4.4B
Free Cash FlowCN¥0
Industry P/E17.5
Technical Analysis
TrendBearish
RSI36.6
SupportCN¥7.83
ResistanceCN¥8.53
MA 20CN¥8.20
MA 50CN¥8.36
MA 200CN¥8.43
MACDBearish
VolumeDecreasing
Fear & Greed Index68.77
Valuation
Fair ValueCN¥7.17
Target PriceCN¥10.77
Upside/Downside35.13%
GradeOvervalued
TypeValue
Dividend Yield2.26%
Risk Assessment
Beta0.20
Volatility18.15%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.